$BRAINSTORM CELL THERAPEUTICS(BCLI)$ BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading         developer of adult stem cell technologies for neurodegenerative         diseases, today announced that Chief Executive Officer Tony         Fiorino, MD, PhD, will be presenting a corporate update at         the 17th Annual BIO CEO & Investor Conference.  Dr. Fiorino is         scheduled to speak at 4:30 PM EST on Monday,         February 9, at the Waldorf Astoria in New         York City, New         York.